A pharmaceutical representative is asked by a physician about a drug's use in a pediatric population, but the drug is only approved for adults. The representative should:
-
A
Provide all available pediatric study data to help the physician
-
B
Decline to discuss it and refer the physician to the company's medical information department
-
C
Share only the most favorable pediatric data available
-
D
Advise the physician to call the FDA directly for guidance